MedMe Health Secures CAD$2.7M Seed Funding


MedMe Health, a Toronto, Canada-based provider of a virtual care and clinical services technology platform, raised CAD$2.7M in Seed funding.

The round was led by  M12, with participation from Graphite Ventures, Y Combinator and MaRS IAF.

The company intends to use the funds to accelerate growth, product development and global expansion.

Led by CEO Purya Sarmadi, MedMe Health a web-based platform supporting pharmacy scheduling, documentation and management of clinical services at scale. Real-time patient engagement, streamlined workflows and automated documentation empower pharmacists to optimize pharmacy operations, build patient relationships and diversify revenue through clinical services. To date the company has facilitated over 14 million unique patient interactions at more than 3,600 pharmacies including Rexall, Shoppers Drug Mart, Jean Coutu Group, Guardian, IDA, The Medicine Shoppe, Remedy’sRx, and Pharmasave. In 2021 the platform enabled pharmacies administer more than 544,000 flu shots, 2,220,000 COVID vaccine doses and more than 155,000 COVID tests. In December 2021 alone the platform booked 760,000 appointments. 

MedMe Health is a Y Combinator W21.